Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Telihep Trio 6.25 Tablet

Prescription Icon
Prescription Required

Marketer

Daylon Healthcare

Salt Composition

Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (6.25mg)

Overview Telihep Trio 6.25 Tablet

Combipress HT 6.25mg is a triple-drug formulation for managing hypertension when monotherapy proves insufficient. It effectively lowers elevated blood pressure, thereby mitigating the risk of future cardiovascular events like stroke and heart attack. Administer Combipress HT 6.25mg with food, at the same time daily, and as directed by your physician. Continue treatment as prescribed; discontinuation may increase stroke or heart attack risk. The medication includes a diuretic, increasing urination, so avoid dosing within four hours of bedtime. Consistent use is crucial for optimal results, even during symptom-free periods (as hypertension often presents asymptomatically). Common side effects include edema (ankle swelling), cephalalgia (headache), vertigo (dizziness), fatigue, and altered taste perception. Report any persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to minimize potential dehydration symptoms such as thirst, dry mouth, and muscle weakness. Prior to initiating treatment, inform your doctor of any pre-existing renal or hepatic impairment, pregnancy, or breastfeeding. Full disclosure of all current medications, particularly those for cardiovascular conditions, is essential. Regular monitoring of blood pressure, renal function, electrolyte balance, and glycemia is necessary to ensure therapeutic efficacy and safety.

Primary Ingredients of Telihep Trio 6.25 Tablet

No text was provided to rewrite.

Uses of Telihep Trio 6.25 Tablet

Elevated blood pressure

Major Benefits of Telihep Trio 6.25 Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Telihep Trio 6.25 Tablet with food.

Common Side effects of Telihep Trio 6.25 Tablet:

  • Ankle swelling
  • Headache
  • Dizziness
  • Tiredness
  • Palpitations
  • Sleepiness
  • Glucose intolerance
  • Taste change
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Upset stomach
  • Altered blood lipid level

How to use Telihep Trio 6.25 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telihep Trio 6.25 Tablet whole; do not chew, crush, or divide it. Administer this medication with food.

How Telihep Trio 6.25 Tablet works:

Telihep Trio 6.25mg tablets contain telmisartan, cilnidipine, and chlorthalidone, working synergistically to manage hypertension. Telmisartan, an angiotensin II receptor antagonist, and cilnidipine, a dihydropyridine calcium channel blocker, both promote vasodilation, reducing blood pressure. Chlorthalidone, a thiazide diuretic, lowers blood pressure by increasing urinary excretion of sodium and water, contributing to overall vascular relaxation and improved circulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Telihep Trio 6.25 Tablet and alcohol is not advisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Telihep Trio 6.25 Tablet during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Telihep Trio 6.25 Tablet with breastfeeding is currently unavailable. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Driving may be unsafe while taking Telihep Trio 6.25 Tablet due to potential side effects including drowsiness, blurred vision, and dizziness, which can impair alertness.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using Telihep Trio 6.25 mg tablets, potentially requiring dosage modification under medical supervision. This medication is not advised for such individuals.

LiverLiverCAUTION

Patients with liver impairment should use Telihep Trio 6.25 Tablet cautiously, potentially requiring dosage modification. A physician's consultation is advised. Telihep Trio 6.25 Tablet is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Telihep Trio 6.25 Tablet :

Should you forget a Telihep Trio 6.25 Tablet dose, administer it at your earliest convenience. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Telihep Trio 6.25 Tablet

LabelValue
Developing Habits No.
Treatment Category Heart
Telihep Trio 6.25 Tablet
104
MRP 120
13% off